Kinetic Capital Partners leads VisCardia's $12.5 mln Series B
U.S. medical device startup VisCardia Inc has closed a US$12.5 million Series B financing. The round was led by Kinetic Capital Partners, a Canadian private equity and late-stage venture capital firm. Founded in 2015, Portland, Oregon-based VisCardia said the funds raised will help it continue development of its novel implantable device therapy for treating heart failure. Concurrent with the Series B, the company said it secured assets and technology rights from Inovise Medical Inc, a medical device specialist also located in Oregon.
7 February 2017•4 mins read
